Hawryluk P. Kent
Insider CIK 1673991 · GEMP Director · MBX President & CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MBX MBX Biosciences, Inc. | S Sale | 2026-05-06 | 2026-05-08 | 607 | $29.54 | $17.9K | 727,667 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2026-03-13 | 2026-03-16 | 18,500 | $28.41 | $525.6K | 486,777 | SEC↗ |
| MBX MBX Biosciences, Inc. | M Exercise deriv | 2026-02-26 | 2026-02-27 | 28,768 | — | $0 | 91,668 | SEC↗ |
| MBX MBX Biosciences, Inc. | M Exercise | 2026-02-26 | 2026-02-27 | 28,768 | $16.00 | $460.3K | 728,274 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2026-02-02 | 2026-02-03 | 164,500 | — | $0 | 164,500 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award | 2026-02-02 | 2026-02-03 | 35,250 | — | $0 | 699,506 | SEC↗ |
| MBX MBX Biosciences, Inc. | M Exercise deriv | 2025-10-24 | 2025-10-28 | 182,859 | — | $0 | 129,708 | SEC↗ |
| MBX MBX Biosciences, Inc. | M Exercise | 2025-10-24 | 2025-10-28 | 182,859 | $3.25 | $594.3K | 664,256 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2025-10-20 | 2025-10-21 | 20,000 | $13.64 | $272.8K | 468,277 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2025-02-04 | 2025-02-05 | 50,000 | $10.69 | $534.5K | 448,277 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2025-02-03 | 2025-02-05 | 243,000 | — | $0 | 243,000 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 1,396,762 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 76,969 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 970,873 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 345,705 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 2,015,681 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 115,914 | — | $0 | 398,277 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 283,846 | — | $0 | 481,397 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2024-09-12 | 2024-09-13 | 120,436 | — | $0 | 120,436 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | A Award deriv | 2018-01-29 | 2018-01-30 | 10,800 | — | $0 | 10,800 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | P Buy deriv | 2017-03-10 | 2017-03-14 | 18,750 | $9.47 | $177.6K | 18,750 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | P Buy | 2017-03-10 | 2017-03-14 | 25,000 | $9.47 | $236.8K | 81,889 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | C Conversion deriv | 2016-08-10 | 2016-08-12 | 0 | — | $0 | 0 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | C Conversion deriv | 2016-08-10 | 2016-08-12 | 7,457 | — | $0 | 0 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | C Conversion | 2016-08-10 | 2016-08-12 | 23,616 | $6.71 | $158.5K | 31,889 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | P Buy | 2016-08-10 | 2016-08-12 | 25,000 | $10.00 | $250.0K | 56,889 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | J Other | 2016-08-10 | 2016-08-12 | 816 | $6.71 | $5.5K | 8,273 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | C Conversion | 2016-08-10 | 2016-08-12 | 7,457 | — | $0 | 7,457 | SEC↗ |
| GEMP Gemphire Therapeutics Inc. | A Award deriv | 2016-08-04 | 2016-08-08 | 60,000 | — | $0 | 60,000 | SEC↗ |